Glen Santangelo
Stock Analyst at Barclays
(2.33)
# 2,555
Out of 5,172 analysts
131
Total ratings
42.86%
Success rate
-1.09%
Average return
Main Sectors:
Stocks Rated by Glen Santangelo
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PGNY Progyny | Maintains: Overweight | $29 → $23 | $18.13 | +26.86% | 6 | Mar 20, 2026 | |
| ALGN Align Technology | Upgrades: Overweight | $200 | $173.18 | +15.49% | 4 | Mar 17, 2026 | |
| HIMS Hims & Hers Health | Maintains: Overweight | $25 → $29 | $22.02 | +31.70% | 7 | Mar 11, 2026 | |
| TALK Talkspace | Maintains: Equal-Weight | $5.5 → $5.25 | $5.14 | +2.14% | 3 | Mar 10, 2026 | |
| BHC Bausch Health Companies | Maintains: Equal-Weight | $8 → $7 | $5.01 | +39.72% | 2 | Feb 25, 2026 | |
| OGN Organon & Co. | Maintains: Underweight | $7.5 → $8 | $6.03 | +32.67% | 2 | Feb 24, 2026 | |
| CAH Cardinal Health | Maintains: Overweight | $243 → $258 | $207.83 | +24.14% | 6 | Feb 24, 2026 | |
| MCK McKesson | Maintains: Overweight | $960 → $1,050 | $885.84 | +18.53% | 7 | Feb 18, 2026 | |
| HQY HealthEquity | Maintains: Overweight | $118 → $110 | $81.02 | +35.77% | 8 | Feb 18, 2026 | |
| COR Cencora | Maintains: Overweight | $400 → $425 | $326.91 | +30.01% | 2 | Feb 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $24 → $34 | $24.89 | +36.60% | 3 | Feb 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $63 → $38 | $24.41 | +55.67% | 4 | Feb 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $850 → $800 | $577.26 | +38.59% | 2 | Feb 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $35 → $38 | $28.73 | +32.27% | 7 | Jan 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $5.25 → $2.75 | $2.03 | +35.47% | 3 | Jan 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $50 | $42.73 | +17.01% | 1 | Jan 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $58 → $56 | $35.44 | +58.01% | 5 | Jan 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $26 → $24 | $11.86 | +102.36% | 3 | Dec 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $136 | $115.67 | +17.58% | 2 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $9 | $5.44 | +65.44% | 3 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $15 | $13.20 | +13.64% | 5 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $8.5 | $5.35 | +58.88% | 8 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $100 | $64.51 | +55.01% | 1 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $16 | $11.21 | +42.73% | 2 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $27 | $22.11 | +22.12% | 6 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $86 | $72.29 | +18.97% | 3 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $30 | $23.98 | +25.10% | 2 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underweight | $12 | $10.95 | +9.59% | 3 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $100 | $74.67 | +33.92% | 2 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $30 | $19.50 | +53.85% | 3 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $15 | $11.83 | +26.80% | 1 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $49 | $30.74 | +59.40% | 1 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underweight | $5 | $3.53 | +41.64% | 1 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $51 | $24.07 | +111.88% | 1 | Feb 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $100 | $5.45 | +1,734.86% | 2 | Dec 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $55 | $72.97 | -24.63% | 1 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $31 → $28 | $1.23 | +2,176.42% | 2 | Mar 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $120 | $5.73 | +1,994.24% | 3 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $36 | $1.13 | +3,085.84% | 1 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $71.48 | - | 3 | Mar 17, 2021 |
Progyny
Mar 20, 2026
Maintains: Overweight
Price Target: $29 → $23
Current: $18.13
Upside: +26.86%
Align Technology
Mar 17, 2026
Upgrades: Overweight
Price Target: $200
Current: $173.18
Upside: +15.49%
Hims & Hers Health
Mar 11, 2026
Maintains: Overweight
Price Target: $25 → $29
Current: $22.02
Upside: +31.70%
Talkspace
Mar 10, 2026
Maintains: Equal-Weight
Price Target: $5.5 → $5.25
Current: $5.14
Upside: +2.14%
Bausch Health Companies
Feb 25, 2026
Maintains: Equal-Weight
Price Target: $8 → $7
Current: $5.01
Upside: +39.72%
Organon & Co.
Feb 24, 2026
Maintains: Underweight
Price Target: $7.5 → $8
Current: $6.03
Upside: +32.67%
Cardinal Health
Feb 24, 2026
Maintains: Overweight
Price Target: $243 → $258
Current: $207.83
Upside: +24.14%
McKesson
Feb 18, 2026
Maintains: Overweight
Price Target: $960 → $1,050
Current: $885.84
Upside: +18.53%
HealthEquity
Feb 18, 2026
Maintains: Overweight
Price Target: $118 → $110
Current: $81.02
Upside: +35.77%
Cencora
Feb 13, 2026
Maintains: Overweight
Price Target: $400 → $425
Current: $326.91
Upside: +30.01%
Feb 11, 2026
Maintains: Overweight
Price Target: $24 → $34
Current: $24.89
Upside: +36.60%
Feb 11, 2026
Maintains: Overweight
Price Target: $63 → $38
Current: $24.41
Upside: +55.67%
Feb 5, 2026
Maintains: Overweight
Price Target: $850 → $800
Current: $577.26
Upside: +38.59%
Jan 30, 2026
Maintains: Overweight
Price Target: $35 → $38
Current: $28.73
Upside: +32.27%
Jan 22, 2026
Downgrades: Hold
Price Target: $5.25 → $2.75
Current: $2.03
Upside: +35.47%
Jan 12, 2026
Initiates: Overweight
Price Target: $50
Current: $42.73
Upside: +17.01%
Jan 9, 2026
Maintains: Overweight
Price Target: $58 → $56
Current: $35.44
Upside: +58.01%
Dec 16, 2025
Maintains: Overweight
Price Target: $26 → $24
Current: $11.86
Upside: +102.36%
Dec 9, 2025
Initiates: Equal-Weight
Price Target: $136
Current: $115.67
Upside: +17.58%
Dec 9, 2025
Initiates: Overweight
Price Target: $9
Current: $5.44
Upside: +65.44%
Dec 9, 2025
Initiates: Overweight
Price Target: $15
Current: $13.20
Upside: +13.64%
Dec 9, 2025
Initiates: Equal-Weight
Price Target: $8.5
Current: $5.35
Upside: +58.88%
Dec 9, 2025
Initiates: Overweight
Price Target: $100
Current: $64.51
Upside: +55.01%
Dec 9, 2025
Initiates: Equal-Weight
Price Target: $16
Current: $11.21
Upside: +42.73%
Dec 9, 2025
Initiates: Equal-Weight
Price Target: $27
Current: $22.11
Upside: +22.12%
Dec 9, 2025
Initiates: Overweight
Price Target: $86
Current: $72.29
Upside: +18.97%
Dec 9, 2025
Initiates: Overweight
Price Target: $30
Current: $23.98
Upside: +25.10%
Dec 9, 2025
Initiates: Underweight
Price Target: $12
Current: $10.95
Upside: +9.59%
Dec 9, 2025
Initiates: Overweight
Price Target: $100
Current: $74.67
Upside: +33.92%
Dec 9, 2025
Initiates: Equal-Weight
Price Target: $30
Current: $19.50
Upside: +53.85%
Dec 9, 2025
Initiates: Overweight
Price Target: $15
Current: $11.83
Upside: +26.80%
Dec 9, 2025
Initiates: Overweight
Price Target: $49
Current: $30.74
Upside: +59.40%
Dec 9, 2025
Initiates: Underweight
Price Target: $5
Current: $3.53
Upside: +41.64%
Feb 11, 2025
Initiates: Buy
Price Target: $51
Current: $24.07
Upside: +111.88%
Dec 15, 2023
Reiterates: Buy
Price Target: $100
Current: $5.45
Upside: +1,734.86%
Oct 21, 2022
Initiates: Hold
Price Target: $55
Current: $72.97
Upside: -24.63%
Mar 17, 2022
Upgrades: Buy
Price Target: $31 → $28
Current: $1.23
Upside: +2,176.42%
Dec 2, 2021
Initiates: Hold
Price Target: $120
Current: $5.73
Upside: +1,994.24%
Dec 2, 2021
Initiates: Buy
Price Target: $36
Current: $1.13
Upside: +3,085.84%
Mar 17, 2021
Downgrades: Neutral
Price Target: n/a
Current: $71.48
Upside: -